PHILADELPHIA – April 28, 2021 – ERT, a global leader in clinical endpoint data solutions, today announced the close of its merger with Bioclinica, a technological and scientific leader in clinical imaging. This combination creates the global leader in clinical trial endpoint technology and leading partner to pharmaceutical and biotechnology companies, providing best-in-class technology, scientific and therapeutic expertise, and digital innovation with an unrelenting focus on customer service.

For more information, visit: ERT and Bioclinica Close Merger, Creating the Global Leader in Clinical Trial Endpoint Technology | ERT